Similar medications and substitutes for VEDOLIZUMAB
In short: Entyvio (VEDOLIZUMAB) belongs to the Integrin Receptor Antagonist class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Entyvio is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Entyvio in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.